How do you pay?

How to pay the least

Ask for the cash price

Restasis MultiDose

The FDA has approved one in this form, but it isn’t in pharmacies yet. Other forms or strengths are sold, but switching to one would need a new prescription.

  1. Ask your pharmacy for Restasis MultiDose’s cash price, and one or two other pharmacies too.
  2. Restasis MultiDose’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify myAbbVie Assist. Our income guidelines are based on the size of your household and annual income. Or call 1-800-222-6885.

See if you qualify 

Compare every option

Question
Brand nameRestasis MultiDose
Authorized genericcyclosporine
Regular genericcyclosporine
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Other forms onlyAsk your doctor
Same as the brand?
The original
–
–

Brand nameThe maker’s card

RESTASIS® Savings Program

Savings card from AbbVie (Allergan)

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

The card takes up to $1,200 a year off your co-pay.

Sign up on restasis.com 

Or call 1-844-469-8327.

In the maker’s words

“Depending on your insurance coverage, most eligible patients may pay as little as $0 per 30-day supply for each of up to twelve (12)”

From the maker’s offer on restasis.com, checked October 26, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Restasis MultiDose itself, from the same company, sold without the brand name, and usually for less. For now Restasis MultiDose is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

The FDA has approved one in this form, but it isn’t in pharmacies yet. Other forms or strengths are sold, but switching to one would need a new prescription. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

RESTASIS MULTIDOSE is a calcineurin inhibitor immunosuppressant indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca. Increased tear production was not seen in patients currently taking topical anti-inflammatory drugs or using punctal plugs.

Source: the FDA label for Restasis MultiDose (Allergan, Inc.), August 21, 2025. Full label on DailyMed 

Good to know